Bangladesh Grapples with Rising Dengue Cases Amid Global Concerns

Dhaka, Bangladesh – Bangladesh is currently experiencing a significant surge in dengue fever cases, prompting heightened concerns from health officials and a nationwide mobilization of preventative measures. As of late October, the Directorate General of Health Services (DGHS) reports over 1,300 confirmed cases of dengue this year, a substantial increase compared to the same period last year. While the majority of cases are concentrated in Dhaka, instances are being reported across multiple districts, raising fears of a wider outbreak.

Health experts attribute the rise to a combination of factors, including unusually heavy monsoon rains creating widespread stagnant water – the breeding ground for the Aedes mosquito, the vector responsible for transmitting the dengue virus – and increasingly erratic weather patterns linked to climate change. The DGHS has initiated public awareness campaigns emphasizing the importance of eliminating mosquito breeding sites around homes and workplaces. These campaigns include door-to-door visits by health workers, distribution of mosquito nets, and public service announcements on television and radio.

The current strain of dengue circulating in Bangladesh is primarily DENV-2, known for causing more severe symptoms. Symptoms typically include high fever, severe headache, muscle and joint pain, nausea, vomiting, and rash. In severe cases, dengue can lead to hemorrhagic fever, shock, and even death. Hospitals in Dhaka are reporting a strain on resources, with many operating near capacity. The government has directed hospitals to increase bed availability and ensure adequate supplies of intravenous fluids and blood products.

Beyond Bangladesh, global health organizations are also observing an increase in dengue incidence worldwide. The World Health Organization (WHO) recently highlighted a concerning trend of expanding geographic distribution of the disease, with outbreaks reported in previously unaffected regions of Europe and the Americas. This expansion is attributed to factors such as increased international travel and climate change, which is facilitating the spread of mosquito vectors to new areas.

Dr. Maria Van Kerkhove, WHO’s Acting for Technical Leads for COVID-19, Disease Control and Prevention, emphasized the need for a coordinated global response to combat dengue. “We are seeing an increase in dengue cases globally, and this is a reminder that vector-borne diseases remain a significant public health threat,” she stated in a recent press briefing. “Strengthening surveillance, improving vector control, and developing effective vaccines are crucial steps in mitigating the impact of dengue.”

Several dengue vaccines are currently available, but their efficacy varies depending on the serotype and the recipient’s prior exposure to the virus. The WHO recommends the use of the Dengvaxia vaccine only in individuals with confirmed prior dengue infection. A newer vaccine, Qdenga, has shown promising results in clinical trials and has been approved for use in some countries, including the European Union and Indonesia. Bangladesh is currently evaluating the feasibility of incorporating these vaccines into its national immunization program.

The DGHS is urging citizens to take proactive measures to protect themselves from mosquito bites, including wearing long sleeves and pants, using mosquito repellent, and sleeping under mosquito nets. They also advise seeking immediate medical attention if they experience symptoms of dengue fever. The situation remains fluid, and health officials are closely monitoring the trend to implement further preventative measures as needed. The long-term impact of climate change on the spread of dengue remains a significant concern for Bangladesh and the global health community.